Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

145 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-01

Study Completion Date

2018-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the effect of statin for primary prevention, towards lowering the incidence of recurrent myocardial infarction, cardiogenic shock and mortality in ACS patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prior Statin Use and Risk of CHF, ALO and Malignant Arrhythmia in Indonesian Post-Acute Coronary Syndrome Patients

NCT03596931

Acute Coronary Syndrome Acute Pulmonary Edema Arrhythmias, Cardiac +1 more

COMPLETED

Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct

NCT05709509

ST Elevation Myocardial Infarction Colchicine Cardiac Remodeling, Ventricular

UNKNOWN PHASE4

Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome

NCT01223586

Statin Coronary Plaque Acute Coronary Syndrome +2 more

COMPLETED

Real World Evidence Study of Statin Use in Brazil

NCT05285085

Cardiovascular Diseases Myocardial Infarction Stroke +3 more

COMPLETED

Effects of Intensive Statin Treatment on Left Ventricular Function

NCT01936103

Acute Anterior Myocardial Infarction

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adult patients (≥ 18 years of age) with acute coronary syndrome which are diagnosed under ICD-10 coding of I24.9 were included in this study. The inclusion criteria are patients with primary diagnosis of I24.9 and with a complete record of prior medical and treatment history, electrocardiographic findings, cardiac marker results and outcomes. Participants were grouped into 2 groups - statin and non-statin based on prior history of statin use prior to ACS. Diagnosis of ACS was made based on clinical, electrocardiographic and cardiac marker findings found in the medical record.

Data such as age, sex, ethnic, education, prior medical and treatment history, electrocardiographic and cardiac enzyme results as well as outcomes were collected from the patients' medical records. Outcomes of interest were defined as either recurrent myocardial infarction, cardiogenic shock, mortality or combinations of them as diagnosed in the medical records. GRACE and TIMI Scores are calculated to predict in hospital and future mortality rates.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Recurrent Myocardial Infarction Cardiogenic Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Statin

History of statin use for primary prevention

Statin

Intervention Type DRUG

Prescribed with statins for primary prevention

Non-Statin

No documented history of statin use prior to Acute Coronary Syndrome

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Statin

Prescribed with statins for primary prevention

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of Acute Coronary Syndrome
* Presence of detail on statin prescription history

Exclusion Criteria

* Unavailability of electrocardiographic findings, cardiac marker results, GRACE and TIMI score parameters
* Incomplete records of prior medical and treatment history

Eligible Sex

ALL

Accepts Healthy Volunteers

No